Cargando…
The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors
Background: There is limited evidence on the effect of low birthweight on the use of cardiovascular medications and the role of health behaviors. This study aims to determine the independent effect of low birthweight and its combination with adult health behaviors on the number of dispensed cardiova...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607150/ https://www.ncbi.nlm.nih.gov/pubmed/37887873 http://dx.doi.org/10.3390/jcdd10100426 |
_version_ | 1785127478536175616 |
---|---|
author | Mo, Minjia Thiesmeier, Robert Kiwango, George Rausch, Christian Möller, Jette Liang, Yajun |
author_facet | Mo, Minjia Thiesmeier, Robert Kiwango, George Rausch, Christian Möller, Jette Liang, Yajun |
author_sort | Mo, Minjia |
collection | PubMed |
description | Background: There is limited evidence on the effect of low birthweight on the use of cardiovascular medications and the role of health behaviors. This study aims to determine the independent effect of low birthweight and its combination with adult health behaviors on the number of dispensed cardiovascular medications. Methods: We included 15618 participants with information on birthweight and self-reported health behaviors. Dispensed cardiovascular medications were identified from the Prescribed Drug Register based on a three-digit level Anatomical Therapeutic Chemical classification code (C01 to C10 and B01) and categorized into 0, 1, and ≥2 different types of medications. We applied multinomial logistic regression models estimating odds ratios (ORs) and 95% confidence intervals (CIs). Results: Participants with low birthweight had a higher estimated OR of using ≥2 types of cardiovascular medications (OR = 1.46, 95% CI = 1.06, 2.01). Further, an increased risk for using ≥2 types of cardiovascular medications was found in participants with poor health behaviors for normal (OR = 2.17, 95% CI = 1.80, 2.62) and high (OR = 1.84, 95% CI = 1.29, 2.62) birthweight. The strongest effect on using ≥2 types of cardiovascular medications was found for low birthweight and poor health behaviors (OR = 3.14, 95% CI = 1.80, 5.50). Conclusion: This cohort study provides evidence that low birthweight increases the risk of using more types of cardiovascular medications in adulthood. This study also suggests that ideal health behaviors reduce this risk. |
format | Online Article Text |
id | pubmed-10607150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106071502023-10-28 The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors Mo, Minjia Thiesmeier, Robert Kiwango, George Rausch, Christian Möller, Jette Liang, Yajun J Cardiovasc Dev Dis Article Background: There is limited evidence on the effect of low birthweight on the use of cardiovascular medications and the role of health behaviors. This study aims to determine the independent effect of low birthweight and its combination with adult health behaviors on the number of dispensed cardiovascular medications. Methods: We included 15618 participants with information on birthweight and self-reported health behaviors. Dispensed cardiovascular medications were identified from the Prescribed Drug Register based on a three-digit level Anatomical Therapeutic Chemical classification code (C01 to C10 and B01) and categorized into 0, 1, and ≥2 different types of medications. We applied multinomial logistic regression models estimating odds ratios (ORs) and 95% confidence intervals (CIs). Results: Participants with low birthweight had a higher estimated OR of using ≥2 types of cardiovascular medications (OR = 1.46, 95% CI = 1.06, 2.01). Further, an increased risk for using ≥2 types of cardiovascular medications was found in participants with poor health behaviors for normal (OR = 2.17, 95% CI = 1.80, 2.62) and high (OR = 1.84, 95% CI = 1.29, 2.62) birthweight. The strongest effect on using ≥2 types of cardiovascular medications was found for low birthweight and poor health behaviors (OR = 3.14, 95% CI = 1.80, 5.50). Conclusion: This cohort study provides evidence that low birthweight increases the risk of using more types of cardiovascular medications in adulthood. This study also suggests that ideal health behaviors reduce this risk. MDPI 2023-10-15 /pmc/articles/PMC10607150/ /pubmed/37887873 http://dx.doi.org/10.3390/jcdd10100426 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mo, Minjia Thiesmeier, Robert Kiwango, George Rausch, Christian Möller, Jette Liang, Yajun The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors |
title | The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors |
title_full | The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors |
title_fullStr | The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors |
title_full_unstemmed | The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors |
title_short | The Association between Birthweight and Use of Cardiovascular Medications: The Role of Health Behaviors |
title_sort | association between birthweight and use of cardiovascular medications: the role of health behaviors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607150/ https://www.ncbi.nlm.nih.gov/pubmed/37887873 http://dx.doi.org/10.3390/jcdd10100426 |
work_keys_str_mv | AT mominjia theassociationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT thiesmeierrobert theassociationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT kiwangogeorge theassociationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT rauschchristian theassociationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT mollerjette theassociationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT liangyajun theassociationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT mominjia associationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT thiesmeierrobert associationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT kiwangogeorge associationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT rauschchristian associationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT mollerjette associationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors AT liangyajun associationbetweenbirthweightanduseofcardiovascularmedicationstheroleofhealthbehaviors |